High expression of class III β‑tubulin in small cell lung carcinoma

  • Authors:
    • Steven Powell
    • Alex Kaizer
    • Joseph S. Koopmeiners
    • Carlos Iwamoto
    • Mark Klein
  • View Affiliations

  • Published online on: December 6, 2013     https://doi.org/10.3892/ol.2013.1734
  • Pages: 405-410
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Class III β‑tubulin (TUBB3) is emerging as a biomarker in a number of cancers. TUBB3 has been shown to be a prognostic indicator of more aggressive disease and a predictor of resistance to taxanes and vinca alkaloids. To date, there is little data on TUBB3 expression in small cell lung carcinoma (SCLC). The primary objective of this study was to determine the expression of TUBB3 in SCLC. Immunohistochemical staining of SCLC tumor specimens was performed using standard procedures. Expression of TUBB3 was determined as a composite of the percentage of malignant cells staining positive and the intensity of staining. Clinical and tumor data for each patient was compared with the degree of TUBB3 expression. A total of 66 SCLCs were evaluable for TUBB3 expression. The majority of specimens (n=56, 85%) had high expression of TUBB3. Only 4.5% (n=3) had low expression of TUBB3. The mean distribution of positive staining for the specimens was 87.3±1.8% (mean ± SE). Specimens from core biopsies were significantly more likely to have high TUBB3 expression when compared with fine needle aspirates (P=0.004). There were no other significant findings when comparing clinical or tumor characteristics. Overall, we found that expression of TUBB3 in SCLC is higher than expected. Innate resistance to microtubule inhibitors, such as the taxanes and vinca alkaloids, may be associated with this finding. Attempts at microtubule inhibition with novel agents may be able to overcome this resistance mechanism. Further evaluation of TUBB3 as a biomarker in SCLC is warranted.
View Figures
View References

Related Articles

Journal Cover

2014-February
Volume 7 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Powell S, Kaizer A, Koopmeiners JS, Iwamoto C and Klein M: High expression of class III β‑tubulin in small cell lung carcinoma. Oncol Lett 7: 405-410, 2014.
APA
Powell, S., Kaizer, A., Koopmeiners, J.S., Iwamoto, C., & Klein, M. (2014). High expression of class III β‑tubulin in small cell lung carcinoma. Oncology Letters, 7, 405-410. https://doi.org/10.3892/ol.2013.1734
MLA
Powell, S., Kaizer, A., Koopmeiners, J. S., Iwamoto, C., Klein, M."High expression of class III β‑tubulin in small cell lung carcinoma". Oncology Letters 7.2 (2014): 405-410.
Chicago
Powell, S., Kaizer, A., Koopmeiners, J. S., Iwamoto, C., Klein, M."High expression of class III β‑tubulin in small cell lung carcinoma". Oncology Letters 7, no. 2 (2014): 405-410. https://doi.org/10.3892/ol.2013.1734